MedTrace Logo

Exercise Intervention in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

NCT05255172 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-06-29

No results posted yet for this study

Summary

The objective of this study is to assess by what physiological mechanisms patients with heart failure benefit from exercise. Effects of an exercise intervention will be assessed for both central (heart and lungs) and peripheral (muscle fiber and mitochondria) factors.

Conditions

  • Heart Failure New York Heart Association (NYHA) Class II
  • Heart Failure New York Heart Association (NYHA) Class III

Interventions

OTHER

Supervised Exercise

12 weeks of supervised aerobic exercise individually adapted to exercise capacity according to a VO2 peak test

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2027-08-31
Completion
2027-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05255172 on ClinicalTrials.gov